$19.25
+0.65 (+3.49%)
Open$18.19
Previous Close$18.60
Day High$20.00
Day Low$18.19
52W High$12.11
52W Low$7.68
Volume—
Avg Volume728.4K
Market Cap21.24M
P/E Ratio27.95
EPS$0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
-35.6% upside
Current
$19.25
$19.25
Target
$12.39
$12.39
$7.78
$12.39 avg
$16.73
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.59M | 4.05M | 3.58M |
| Net Income | -196,564 | -196,089 | -156,693 |
| Profit Margin | -4.3% | -4.8% | -4.4% |
| EBITDA | -265,994 | -241,454 | -219,779 |
| Free Cash Flow | -252,687 | -239,821 | -142,632 |
| Rev Growth | +16.2% | +0.5% | -3.6% |
| Debt/Equity | 1.06 | 0.93 | 0.96 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |